Sex differences in arterial hypertension: a scientific statement from the ESC Council on Hypertension, the European Association of Preventive Cardiology, Association …

E Gerdts, I Sudano, S Brouwers, C Borghi… - European Heart …, 2022 - academic.oup.com
There is strong evidence that sex chromosomes and sex hormones influence blood
pressure (BP) regulation, distribution of cardiovascular (CV) risk factors and co-morbidities …

[HTML][HTML] Sex differences in lipid and lipoprotein metabolism

BT Palmisano, L Zhu, RH Eckel, JM Stafford - Molecular metabolism, 2018 - Elsevier
Background Endogenous sex hormones are important for metabolic health in men and
women. Before menopause, women are protected from atherosclerotic cardiovascular …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys

B Zhou, G Danaei, GA Stevens, H Bixby, C Taddei… - The Lancet, 2019 - thelancet.com
Background Antihypertensive medicines are effective in reducing adverse cardiovascular
events. Our aim was to compare hypertension awareness, treatment, and control, and how …

Menopausal hormone replacement therapy and reduction of all-cause mortality and cardiovascular disease: it is about time and timing

HN Hodis, WJ Mack - The Cancer Journal, 2022 - journals.lww.com
The totality of evidence indicates menopausal hormone replacement therapy (HRT) effects
are determined by timing of initiation according to age and/or time since menopause …

Systematic review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management …

DM Reboussin, NB Allen, ME Griswold, E Guallar… - Circulation, 2018 - ahajournals.org
Objective To review the literature systematically and perform meta-analyses to address
these questions: 1) Is there evidence that self-measured blood pressure (BP) without other …

2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension

TD Wang, CE Chiang, TH Chao… - Acta Cardiologica …, 2022 - pmc.ncbi.nlm.nih.gov
Hypertension is the most important modifiable cause of cardiovascular (CV) disease and all-
cause mortality worldwide. Despite the positive correlations between blood pressure (BP) …

The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases

XC Li, J Zhang, JL Zhuo - Pharmacological research, 2017 - Elsevier
The renin-angiotensin system (RAS) is undisputedly one of the most prominent endocrine
(tissue-to-tissue), paracrine (cell-to-cell) and intracrine (intracellular/nuclear) vasoactive …

Sex-and gender-based pharmacological response to drugs

F Mauvais-Jarvis, HK Berthold, I Campesi… - Pharmacological …, 2021 - Elsevier
In humans, the combination of all sex-specific genetic, epigenetic, and hormonal influences
of biologic sex produces different in vivo environments for male and female cells. We dissect …